Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Decker

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|January 1, 1972
Advanced ovarian cancer: therapy with radiation and cyclophosphamide in a random seriesC E Johnson, D G Decker, M Van Herik, et al.
Cancer Research|April 1, 1977
Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormonesE Adam, D G Decker, A L Herbst, et al.
Gynecologic Oncology|April 1, 1981
Treatment of recurrent and metastatic carcinoma of the cervix: comparison of doxorubicin with a combination of vincristine and 5-fluorouracilG D Malkasian, D G Decker, S J Green, et al.
Obstetrics and Gynecology|October 1, 1982
Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinomaD G Decker, T R Fleming, G D Malkasian, et al.
Obstetrics and Gynecology|May 1, 1974
Mesonephric (clear cell) carcinoma of the vagina and cervix. A retrospective analysisK L Noller, D G Decker, M B Dockerty, et al.
Obstetrics and Gynecology|July 1, 1985
Effects of progestational agents in treatment of endometrial carcinomaK C Podratz, P C O'Brien, G D Malkasian, et al.
JAMA|December 9, 1983
Staging laparotomy in early ovarian cancerR C Young, D G Decker, J T Wharton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinomaJ H Edmonson, T R Fleming, D G Decker, et al.
The New England Journal of Medicine|April 12, 1990
Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trialsR C Young, L A Walton, S S Ellenberg, et al.
Cancer Treatment Reports|February 1, 1979
Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual diseaseJ H Edmonson, T R Fleming, D G Decker, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|January 1, 1972
Advanced ovarian cancer: therapy with radiation and cyclophosphamide in a random seriesC E Johnson, D G Decker, M Van Herik, et al.
Cancer Research|April 1, 1977
Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormonesE Adam, D G Decker, A L Herbst, et al.
Gynecologic Oncology|April 1, 1981
Treatment of recurrent and metastatic carcinoma of the cervix: comparison of doxorubicin with a combination of vincristine and 5-fluorouracilG D Malkasian, D G Decker, S J Green, et al.
Obstetrics and Gynecology|October 1, 1982
Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinomaD G Decker, T R Fleming, G D Malkasian, et al.
Obstetrics and Gynecology|May 1, 1974
Mesonephric (clear cell) carcinoma of the vagina and cervix. A retrospective analysisK L Noller, D G Decker, M B Dockerty, et al.
Obstetrics and Gynecology|July 1, 1985
Effects of progestational agents in treatment of endometrial carcinomaK C Podratz, P C O'Brien, G D Malkasian, et al.
JAMA|December 9, 1983
Staging laparotomy in early ovarian cancerR C Young, D G Decker, J T Wharton, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
Chemotherapeutic sensitivity of minimal residual disease following surgical excision of ovarian carcinomaJ H Edmonson, T R Fleming, D G Decker, et al.
The New England Journal of Medicine|April 12, 1990
Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trialsR C Young, L A Walton, S S Ellenberg, et al.
Cancer Treatment Reports|February 1, 1979
Different chemotherapeutic sensitivities and host factors affecting prognosis in advanced ovarian carcinoma versus minimal residual diseaseJ H Edmonson, T R Fleming, D G Decker, et al.
Pageof 5